Matthias Brandlmaier

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
The Value of Adjuvant Radiotherapy in the Treatment of Melanoma: A Multi-Center Analysis.

|Jan 11, 2025
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive Review.

Magdalena Hoellwerth, Matthias Brandlmaier, Peter Koelblinger

|Nov 20, 2024
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis.

M Brandlmaier, M Hoellwerth, T Silly

|Apr 27, 2024
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation.

Matthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger

Pageof 1

Frequent Collaborators

5 joint publications

Peter Koelblinger

3 joint publications

Magdalena Hoellwerth

2 joint publications

Reinhard Dummer

1 joint publications

L Koch